Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 262 posts found.

Bayer to buy Steigerwald

May 21, 2013
Sales and Marketing Bayer, steigerwald

Bayer is to buy herbal medicines specialist Steigerwald Arzneimittelwerk in a deal which it says is motivated in part by …

News
Xarelto image

German regulator assesses more drugs

April 22, 2013
Sales and Marketing AMNOG, Bayer, Germany, Pradaxa, Xarelto

A new raft of drugs which will be subject to potentially stringent cost/benefit analysis in Germany has been announced. The …

News
Xarelto image

Xarelto gets EU nod

March 25, 2013
Sales and Marketing Bayer, Xarelto

Bayer HealthCare has been given a boost by the recommendation in Europe of its oral blood thinner Xarelto to prevent …

News
Xarelto image

New AF possibility for Xarelto

March 11, 2013
Sales and Marketing Bayer, FDA, Xarelto

Bayer HealthCare is to launch a new trial of its oral blood thinner Xarelto just days after the FDA knocked …

News

£20m research boost for Scottish biotech

February 11, 2013
Research and Development, Sales and Marketing Bayer, BioCity Scotland, Dundee, EFPIA

BioCity Scotland and the University of Dundee are to play key roles in a newly-launched pan-European drug discovery project. In …

News

Bayer/Janssen seek Xa inhibitor antidote

February 6, 2013
Research and Development, Sales and Marketing Bayer, Janssen, PRT4445, Xarelto

Bayer HealthCare and Janssen Pharmaceuticals have signed a deal with Portola Pharmaceuticals to evaluate the safety of an investigational antidote …

News

Jörg Reinhardt to leave Bayer for Novartis

January 24, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Novartis, Reinhardt

The chairman of the Board and member of the Bayer executive council Dr Jörg Reinhard is stepping down from his …

Appointment
Xarelto image

Bayer cleared of Xarelto ‘breaches’

January 17, 2013
Medical Communications, Sales and Marketing Bayer, PMCPA, Xarelto

Bayer has been found not guilty of making multiple breaches of the ABPI Code of Practice following an anonymous complaint …

News
lucentis

New price and data changes NICE view on Lucentis

January 4, 2013
Sales and Marketing Bayer, Eylea, Lucentis, NICE, Novartis

A new lower price and new data analysis has persuaded NICE to recommend Lucentis for patients with diabetic macular oedema …

News
Bayer image

New boost for drug candidates

December 5, 2012
Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden

A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …

News

Pharmacos ink green manufacturing pact with EU academics

December 3, 2012
Manufacturing and Production Bayer, EU, Pharmacos, Sanofi

A group of top pharma multinationals have set up a public-private partnership dedicated to the development of manufacturing sustainable pharmaceuticals …

News
Eylea image

Eylea approval for wet AMD

November 29, 2012
Sales and Marketing Bayer, Eylea, Lucentis, Novartis, avastin, wet AMD

Bayer HealthCare’s Eylea has been appoved in Europe for the treatment of neovascular age-related macular degeneration (wet AMD). The eye …

News
Xarelto image

Xarelto gets new EU approval

November 21, 2012
Sales and Marketing AF, Bayer, DVT, Xarelto

Bayer’s oral anticoagulant Xarelto has extended its licence in Europe to treat pulmonary embolism (PE) and prevent recurrent deep vein …

News

Bayer to acquire Schiff Nutrition

November 4, 2012
Sales and Marketing Bayer, mergers and acquisitions

Bayer HealthCare is to buy US-based vitamins and nutritional supplements firm Schiff Nutrition International for $1.2 billion.The deal is part …

News
Bayer image

Bayer signs endometriosis pact

October 3, 2012
Research and Development, Sales and Marketing Bayer, Evotec, endometriosis

Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025